Miriam Redrado

1.8k citations
39 papers · 1.1k indexed · h-index 20
Topics
Cancer Cells and Metastasis (9 papers)Lung Cancer Treatments and Mutations (8 papers)Cancer Immunotherapy and Biomarkers (5 papers)

In The Last Decade

Miriam Redrado

38 papers receiving 1.1k citations

Peers

Miriam Redrado
Comparison fields: 5 of 81
  • Molecular Biology 544
  • Oncology 518
  • Cancer Research 270
  • Immunology 233
  • Pulmonary and Respiratory Medicine 177
Replace Julia V. Burnier with:
Julia V. Burnier Canada
Caterina Ieranò Italy
Rajkumar Ganesan United States
Alejandro Parrales United States
Michela Croce Italy
Tsuyoshi Osawa Japan
Claire Fabre France
A. Coates United States
Florian Castet Spain
D A Kirschmann United States
Miriam Redrado relative to Julia V. Burnier Canada Julia V. Burnier's profile →
Citations per field
00.5×2.6×
Julia V. Burnier · 1×
Citations per year

Countries citing papers authored by Miriam Redrado

Since Specialization
Citations

This map shows the geographic impact of Miriam Redrado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Redrado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Redrado more than expected).

Fields of papers citing papers by Miriam Redrado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Redrado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Redrado. The network helps show where Miriam Redrado may publish in the future.

Co-authorship network of co-authors of Miriam Redrado

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Redrado. A scholar is included among the top collaborators of Miriam Redrado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Redrado. Miriam Redrado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 67
4 5
5 1
6 27
7 2
8 45
9 31
10 39
11 49
12 9
13 2
14 71
15 36
16 57
17 32
18 40
19 32
20 42

About Miriam Redrado

Miriam Redrado is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (518 citations), Cancer Research (270 citations) and Ophthalmology (118 citations). Miriam Redrado has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Alfonso Calvo, Leyre Larzábal, Paul Nguewa, Luis M. Montuenga, María Villalba, Alice Agliano, Irene Manrique, Diego Serrano, Anne‐Marie Bleau and Francisco Expósito. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026